Immuneering (IMRX) Shares Issued (2021 - 2024)
Historic Shares Issued for Immuneering (IMRX) over the last 4 years, with Q4 2024 value amounting to $3.5 million.
- Immuneering's Shares Issued rose 4415707.72% to $3.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.2 million, marking a year-over-year increase of 84416.39%. This contributed to the annual value of $4.2 million for FY2024, which is 84416.39% up from last year.
- According to the latest figures from Q4 2024, Immuneering's Shares Issued is $3.5 million, which was up 4415707.72% from $732458.0 recorded in Q1 2024.
- In the past 5 years, Immuneering's Shares Issued ranged from a high of $119.4 million in Q3 2021 and a low of -$27.8 million during Q3 2023
- For the 4-year period, Immuneering's Shares Issued averaged around $11.3 million, with its median value being $193111.0 (2022).
- Over the last 5 years, Immuneering's Shares Issued had its largest YoY gain of 10053559.96% in 2023, and its largest YoY loss of 7436041.83% in 2023.
- Quarter analysis of 4 years shows Immuneering's Shares Issued stood at $119.4 million in 2021, then tumbled by 99.96% to $42098.0 in 2022, then plummeted by 81.39% to $7835.0 in 2023, then surged by 44157.08% to $3.5 million in 2024.
- Its last three reported values are $3.5 million in Q4 2024, $732458.0 for Q1 2024, and $7835.0 during Q4 2023.